Incorrect password
evipedia.ai Suggest Edit

Licorice Root for Health & Longevity

Evidence Review created on 04/27/2026 using AI4L / Opus 4.7

Also known as: Glycyrrhiza glabra, Glycyrrhiza uralensis, Liquorice, Sweet Root, Mulethi, Yashtimadhu, Gan Cao

Motivation

Licorice root (Glycyrrhiza glabra and Glycyrrhiza uralensis) is the underground portion of a leguminous plant used in traditional medicine across the Mediterranean, Middle East, and East Asia for more than two thousand years. Its characteristic sweet taste comes from a plant compound called glycyrrhizin. Modern interest centers on two preparations: whole-root extracts that retain glycyrrhizin, and a processed form with the compound removed to avoid licorice’s most serious adverse effects.

Within longevity-oriented protocols, licorice has earned attention for digestive applications, hormonal modulation, and topical dermatologic use. At the same time, even modest daily intake of glycyrrhizin can raise blood pressure and lower potassium — a tension that shapes nearly every protocol decision around the herb.

This review examines what is known about licorice root’s primary actions, the strength of evidence for its proposed benefits, the populations most at risk for adverse effects, and how the choice between glycyrrhizin-containing and glycyrrhizin-removed forms changes the picture.

Benefits - Risks - Protocol - Conclusion

This section curates high-level expert content that frames the broader case for and against licorice root in a longevity context.

  • DGL Supplements: The Digestive Health Benefits of Licorice Root - Krista Elkins

    An accessible overview of deglycyrrhizinated licorice for upper-gastrointestinal applications, covering mechanisms in mucosal protection, the rationale for removing glycyrrhizin, and practical use cases such as reflux and ulcers.

  • Ask the RD: Adrenal Fatigue - Chris Kresser

    Kresser’s clinical team explains licorice as an HPA-axis (hypothalamic-pituitary-adrenal axis, the body’s central stress-response system) “potentiator” that extends cortisol’s active life rather than increasing its production, and contrasts whole-root licorice (used for adrenal support) with DGL (deglycyrrhizinated licorice, the form with glycyrrhizin removed; used for gut healing).

  • Using Cortisol & Adrenaline to Boost Our Energy & Immune System - Andrew Huberman

    Huberman provides a comprehensive overview of cortisol biology and its tools for regulation, including how botanical agents that interact with cortisol metabolism (such as licorice via 11β-HSD2 — 11-beta-hydroxysteroid dehydrogenase type 2, the enzyme that inactivates cortisol — inhibition) should generally be avoided in the evening and used cautiously by anyone with elevated blood pressure.

  • A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial Findings - Kwon et al., 2020

    A narrative review summarizing clinical trial signals for licorice across digestive, dermatologic, and metabolic domains, alongside the safety boundaries imposed by glycyrrhizin’s mineralocorticoid-like effects.

  • Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review - Pastorino et al., 2018

    A comprehensive narrative review of Glycyrrhiza glabra phytochemistry and pharmacology, covering the principal bioactive constituents (glycyrrhizin, glycyrrhetinic acid, isoflavones, glabridin) and their antibacterial, anti-inflammatory, antiviral, antioxidant, and antidiabetic activities, with attention to traditional uses and toxicology.

Note: A standalone treatment of licorice root by Rhonda Patrick (FoundMyFitness) could not be located despite searching her platform and external indexes; her content does not appear to feature licorice as a focal topic. Likewise, no Peter Attia article or podcast clip dedicated to licorice was found on peterattiamd.com.

Grokipedia

Liquorice

A comprehensive Grokipedia entry covering the botany, glycyrrhizin chemistry, traditional uses, and modern pharmacological profile of licorice root, including the distinction between the plant, its confectionery use, and its medicinal forms.

Examine

Licorice Root

Examine.com’s structured monograph aggregates clinical evidence on licorice’s hormonal, digestive, cardiovascular, and metabolic effects, including evidence grading on each outcome and detailed safety notes on glycyrrhizin.

ConsumerLab

Licorice and DGL Supplements, Candies, and Tea Review

ConsumerLab’s independent test results for eleven licorice and DGL products from major brands, including measured glycyrrhizic acid content (with several DGL products failing to meet expected low-glycyrrhizin specifications).

Systematic Reviews

This section presents the most relevant systematic reviews and meta-analyses on licorice root identified through PubMed.

Mechanism of Action

Licorice root acts through multiple bioactive compounds, with distinct mechanisms relevant to the choice of preparation.

Glycyrrhizin and 11β-HSD2 inhibition. Glycyrrhizin (and its active metabolite glycyrrhetinic acid) inhibits 11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2, the enzyme that converts active cortisol into inactive cortisone in tissues like the kidney). Blocking this enzyme allows cortisol to bind mineralocorticoid receptors, mimicking aldosterone — driving sodium and water retention, potassium loss, and blood pressure elevation. This same mechanism extends the systemic activity of cortisol, the basis for licorice’s traditional use in adrenal support.

Anti-inflammatory and antioxidant flavonoids. Glabridin, liquiritigenin, isoliquiritigenin, and licochalcone A inhibit pro-inflammatory pathways including NF-κB (nuclear factor kappa B, a master regulator of inflammation) and reduce oxidative stress. These flavonoids also account for the antimicrobial activity against organisms such as Helicobacter pylori and Streptococcus mutans.

Estrogenic and anti-androgenic activity. Several licorice flavonoids bind estrogen receptors weakly and inhibit 5-alpha-reductase (an enzyme converting testosterone to its more potent form, dihydrotestosterone) and aromatase, producing modest hormonal effects relevant to menopausal symptoms and androgenic conditions.

Mucosal protection. Both glycyrrhizin and the flavonoid fraction in DGL stimulate mucin secretion, increase prostaglandin E2 in gastric tissue, and prolong mucosal cell life — protecting the gastric and esophageal lining without affecting acid secretion.

Tyrosinase inhibition (topical). Glabridin inhibits tyrosinase (the rate-limiting enzyme in melanin synthesis), the basis for licorice extract’s use in topical depigmenting formulations for melasma and post-inflammatory hyperpigmentation.

Pharmacokinetics. Orally administered glycyrrhizin is hydrolyzed by gut bacteria to glycyrrhetinic acid, which has a terminal half-life of approximately 8–12 hours at typical doses but extends to 24–48 hours at higher doses, explaining the cumulative risk of mineralocorticoid effects with chronic use. Selectivity is limited: glycyrrhetinic acid inhibits both 11β-HSD1 and 11β-HSD2, with somewhat greater potency at 11β-HSD2, and binds the mineralocorticoid receptor directly at higher concentrations. Tissue distribution favors the liver, kidney, and adrenal cortex, with high protein binding (>97%) and enterohepatic recirculation that prolongs systemic exposure. Glycyrrhizin and its constituents weakly inhibit several cytochrome P450 enzymes — most notably CYP3A4 (a liver enzyme that metabolizes a large share of common medications) — at high in vitro exposures; clinical interaction effects are typically modest (10–20% changes in substrate exposure).

Where mechanisms compete. Whole-root licorice provides both mucosal protection and mineralocorticoid effects, while DGL retains the mucosal benefits without the cortisol-extending or blood-pressure effects. This split is the basis for the divergent risk-benefit profiles of the two preparations.

Historical Context & Evolution

Licorice root has one of the longest documented histories of any medicinal plant. It appears in Egyptian papyri (notably the Ebers Papyrus from circa 1500 BCE), in Assyrian medical tablets, and was found in the tomb of Tutankhamun. Theophrastus and Dioscorides described its use for cough and gastric complaints. In Traditional Chinese Medicine, Gan Cao (Chinese licorice, Glycyrrhiza uralensis) is among the most frequently used herbs, prized for “harmonizing” formulations and treating spleen and stomach deficiencies.

Modern medical interest accelerated in 1946 when Dutch physician F. E. Revers reported that a licorice paste was effective for peptic ulcer disease. Subsequent research identified glycyrrhetinic acid as an anti-ulcer agent, and a synthetic derivative (carbenoxolone) was developed and used clinically for ulcers in the 1960s–1970s. The recognition that whole-licorice users developed pseudohyperaldosteronism (a condition mimicking aldosterone excess, producing hypertension, hypokalemia — low blood potassium, and metabolic alkalosis — a shift toward higher blood pH) drove development of deglycyrrhizinated licorice (DGL) in the 1950s–1960s as a safer mucosal agent.

The discovery of 11β-HSD2 in the 1980s clarified the mechanism behind the long-observed mineralocorticoid effects, transforming licorice from a botanical curiosity into a model compound in endocrinology research. More recently, attention has shifted to flavonoids such as glabridin, where structure-activity studies have separated dermatologic and metabolic effects from the glycyrrhizin-driven safety profile.

Expected Benefits

A dedicated search for licorice root’s complete benefit profile was conducted across clinical trial registries, systematic reviews, and integrative medicine sources prior to this section.

High 🟩 🟩 🟩

Reduction of Recurrent Aphthous (Canker) Sore Symptoms

Topical licorice — applied as a 1–5% paste, mouthwash, or adhesive patch — reduces pain, ulcer size, and healing time in recurrent aphthous stomatitis. The proposed mechanism combines anti-inflammatory flavonoid action, antimicrobial effects against Streptococcus mutans and Porphyromonas gingivalis, and elevation of epidermal growth factor levels at the lesion. Evidence rests on a 2023 systematic review of six RCTs (314 patients), all of which showed statistically significant improvement; healing typically occurred within 4–8 days, with no notable adverse events from topical use.

Magnitude: Pain reduction approximately 50–80% versus placebo; healing time shortened by roughly 2–4 days.

Prevention of Postoperative Sore Throat

Topical licorice gargle or lozenge before tracheal intubation reduces the incidence and severity of postoperative sore throat. The mechanism is anti-inflammatory action on the laryngeal and pharyngeal mucosa traumatized during intubation. A 2019 meta-analysis of five RCTs (609 patients) reported a risk ratio of 0.44 (95% CI — confidence interval, the range likely to contain the true value — 0.28–0.69) for sore throat incidence, with trial sequential analysis confirming evidence adequacy. No significant adverse events were reported.

Magnitude: Approximately 56% relative risk reduction in postoperative sore throat incidence.

Medium 🟩 🟩

Symptomatic Relief in Functional Dyspepsia and Gastric Discomfort

Licorice flavonoid extracts (glabridin-rich preparations) and DGL improve indigestion symptoms including epigastric pain, bloating, and nausea. Proposed mechanisms include mucosal protection, mild antispasmodic activity, and inhibition of Helicobacter pylori. Evidence comes from several RCTs of standardized licorice extracts (e.g., GutGard) demonstrating symptom reduction over 30 days, plus traditional clinical use of DGL for non-erosive reflux.

Magnitude: Symptom improvement of 30–50% on validated dyspepsia scales versus placebo.

Topical Skin Lightening for Hyperpigmentation

Glabridin and licorice extracts inhibit tyrosinase, reducing melanin synthesis in conditions including melasma and post-inflammatory hyperpigmentation. Multiple RCTs of topical formulations show measurable improvement in pigmentation indices, often used in combination with hydroquinone or as a standalone agent in those who cannot tolerate hydroquinone. Effects are gradual and require sustained application.

Magnitude: Pigmentation reduction approximately 15–30% on Melasma Area and Severity Index after 8–12 weeks of daily application.

Modest Reduction in Body Weight and BMI

Licorice flavonoid oil and certain whole-root extracts produce small but statistically significant reductions in body weight and BMI, possibly via 11β-HSD inhibition in adipose tissue and modulation of fat metabolism. The 2018 Luís et al. meta-analysis of 26 trials confirmed a small effect; clinical relevance is modest.

Magnitude: Mean weight reduction of approximately 0.4 kg and BMI reduction of approximately 0.15 kg/m² over typical study durations.

Low 🟩

Cortisol Extension for Suspected HPA Hypofunction ⚠️ Conflicted

Glycyrrhizin slows the inactivation of cortisol by 11β-HSD2, prolonging its tissue activity. Some integrative practitioners use whole-root licorice for symptomatic “adrenal fatigue” or low morning cortisol on saliva testing. The conflict: “adrenal fatigue” is not a recognized endocrine diagnosis, and there are no high-quality RCTs validating licorice for HPA hypofunction in otherwise healthy adults. Use rests on mechanistic plausibility plus practitioner experience rather than controlled outcome data.

Magnitude: Not quantified in available studies.

Menopausal Symptom Reduction

Licorice flavonoids show weak phytoestrogenic activity and several small RCTs report reduced hot flash frequency and severity. Effects are smaller than with conventional hormone therapy but may be relevant for those preferring botanical options. Long-term safety in menopause has not been established, and glycyrrhizin’s blood pressure effect is a particular concern in this population.

Magnitude: Approximately 25–35% reduction in hot flash frequency in small RCTs.

Adjunct in Chronic Hepatitis (IV Glycyrrhizin)

Intravenous glycyrrhizin (Stronger Neo-Minophagen C, used in Japan) has shown reductions in transaminases and possibly liver-related mortality in chronic hepatitis B and C. Oral preparations have not replicated these effects, and modern direct-acting antivirals have largely displaced this use.

Magnitude: ALT (alanine aminotransferase, a liver enzyme that rises with hepatocyte injury) reduction of approximately 30–50% on IV protocols; oral evidence inconclusive.

Antimicrobial Effects on Oral Pathogens

Licorice extracts reduce Streptococcus mutans counts and biofilm formation, with implications for caries prevention. Pediatric studies of licorice lollipops and rinses showed measurable bacterial reductions, but long-term clinical caries-incidence data are sparse.

Magnitude: S. mutans count reduction of 50–70% in saliva at 2–4 weeks after intervention.

Speculative 🟨

Longevity and Senescence-Modulating Effects

In vitro and animal studies suggest glabridin and isoliquiritigenin can reduce cellular senescence markers, modulate mTOR (mechanistic target of rapamycin, a central nutrient-sensing pathway involved in aging), and protect against oxidative damage. No human longevity outcome data exist, and the basis is mechanistic and preclinical only.

Neuroprotective Effects

Animal models suggest licochalcone A and glabridin may protect against neurodegeneration via anti-inflammatory and antioxidant pathways. Human trial data are absent; the basis for inclusion is preclinical.

Anti-Cancer Adjunct Activity

Numerous preclinical studies show licorice constituents induce apoptosis in cancer cell lines and modulate p53. No controlled clinical trials in oncology have established benefit, and the basis remains mechanistic and animal-model only.

Benefit-Modifying Factors

  • Genetic variation in 11β-HSD2: Polymorphisms reducing baseline 11β-HSD2 activity (e.g., HSD11B2 — the gene encoding this cortisol-inactivating enzyme — variants associated with apparent mineralocorticoid excess phenotypes) amplify both the cortisol-extending benefits and the cardiovascular risks of glycyrrhizin. Carriers may experience effects at much lower doses.

  • Baseline cortisol status: The “adrenal support” rationale for whole-root licorice is most relevant in individuals with documented low morning cortisol on diurnal salivary testing. Those with normal or elevated baseline cortisol gain little benefit and incur the same blood-pressure risk.

  • Sex differences: Women may experience stronger phytoestrogenic effects (relevant for menopausal symptoms), and several pharmacokinetic studies suggest somewhat higher glycyrrhetinic acid exposure in women per unit dose. Effects on hot flashes are female-specific.

  • Pre-existing hypertension or sodium sensitivity: These conditions blunt or invert the risk-benefit ratio for whole-root licorice — the metabolic and cortisol benefits are offset by larger blood pressure increases.

  • Age-related considerations: Older adults have reduced renal potassium-handling capacity, increased prevalence of hypertension, and higher likelihood of polypharmacy, all of which shift the benefit-risk calculation. Topical and DGL preparations remain reasonable; whole-root licorice is generally less favorable in this group.

  • Helicobacter pylori status: Individuals with confirmed H. pylori infection may derive greater dyspepsia and ulcer-symptom benefit from licorice flavonoid extracts than uninfected individuals, due to the antimicrobial mechanism.

Potential Risks & Side Effects

A dedicated search for the licorice root side effect profile was conducted across drug reference sources (NCCIH, Mayo Clinic, drugs.com, FDA communications, and case-series literature) prior to this section.

High 🟥 🟥 🟥

Hypertension and Pseudohyperaldosteronism

Glycyrrhizin’s inhibition of 11β-HSD2 produces a clinical syndrome of hypertension, hypokalemia, sodium retention, and metabolic alkalosis that mimics primary aldosteronism but with suppressed renin and aldosterone. The 2018 meta-analysis of clinical trials demonstrated a measurable diastolic blood pressure rise even in short-term use. Severity correlates with dose, duration, salt intake, and baseline blood pressure. Effects can persist for weeks after discontinuation due to glycyrrhetinic acid’s prolonged tissue half-life.

Magnitude: Diastolic blood pressure increase of approximately 1.7 mmHg average across trials; individual cases of severe hypertension (systolic >180 mmHg) reported with chronic high intake.

Hypokalemia and Cardiac Arrhythmia

Sustained sodium-potassium imbalance from licorice can produce clinically significant hypokalemia, leading to muscle weakness, rhabdomyolysis (skeletal muscle breakdown that releases muscle proteins into the blood), and cardiac arrhythmias including QT prolongation, torsades de pointes (a life-threatening pattern of irregular heartbeats), and cardiac arrest. The U.S. Food and Drug Administration issued a public warning specifically about black licorice candy in adults over 40 (consuming 2 ounces daily for two weeks could cause arrhythmia). Risk increases with diuretic co-administration and pre-existing cardiac disease.

Magnitude: Serum potassium reductions of 0.3–1.0 mmol/L commonly seen; arrhythmia risk concentrated in chronic high consumers and individuals on potassium-wasting medications.

Medium 🟥 🟥

Edema and Fluid Retention

Sodium retention from mineralocorticoid effects produces peripheral edema, weight gain (water), and worsening of heart failure. Symptoms typically resolve within several weeks of discontinuation, paralleling the elimination of glycyrrhetinic acid.

Magnitude: Weight gain of approximately 1–3 kg from fluid in chronic high-dose users; resolution over 2–6 weeks after stopping.

Hormonal Disruption (Estrogenic and Anti-Androgenic)

Licorice flavonoids exhibit weak estrogenic activity and inhibit 17β-hydroxysteroid dehydrogenase, reducing testosterone in men. Small studies have shown 25–40% testosterone reductions in men consuming several grams of licorice root daily. In women, estrogenic activity may be relevant for those with hormone-sensitive conditions.

Magnitude: Testosterone reduction of approximately 25–40% in men with moderate-to-high oral intake; effect reverses with discontinuation.

Low 🟥

Headache, Lethargy, and Muscle Cramps

These are typically secondary manifestations of hypokalemia and fluid shifts. Resolution follows electrolyte normalization.

Magnitude: Reported in approximately 5–15% of chronic users in case series.

Pregnancy Risks

Observational evidence from Finnish cohorts has linked maternal licorice consumption during pregnancy to preterm delivery and lower cognitive/behavioral scores in offspring, possibly via fetal cortisol exposure. The European Food Safety Authority and several national agencies advise pregnant women to avoid licorice.

Magnitude: Preterm-delivery odds ratios (OR — odds ratio, the odds of an outcome in the exposed group divided by the odds in the unexposed group) of approximately 1.4–2.0 in heavy consumers in observational studies.

Drug Interactions Producing Adverse Effects

See the Key Interactions section for specifics. Risk concentrated in individuals on diuretics, antiarrhythmics, digoxin, or warfarin.

Magnitude: Not quantified in available studies.

Speculative 🟨

Long-Term Cardiovascular Outcomes

Whether chronic moderate licorice consumption (below acute toxicity thresholds) translates into measurable cardiovascular event-rate increases over decades has not been studied directly. The basis for inclusion is the mechanistic plausibility from sustained blood pressure elevation rather than outcome data.

Adrenal Suppression with Chronic Use

Mechanistic reasoning suggests sustained glycyrrhizin-driven cortisol extension could suppress endogenous HPA-axis function via negative feedback, but human evidence of clinically meaningful adrenal suppression from licorice alone is limited to isolated reports.

Risk-Modifying Factors

  • HSD11B2 polymorphisms: Reduced enzyme activity at baseline (genetic or due to age) substantially amplifies hypertension and hypokalemia risk from glycyrrhizin.

  • Baseline blood pressure and renal function: Pre-existing hypertension, chronic kidney disease, or low eGFR (estimated glomerular filtration rate, a measure of kidney filtration) sharply increases adverse mineralocorticoid effects.

  • Sex differences: Some pharmacokinetic data suggest women may have higher glycyrrhetinic acid exposure per dose; women in the menopausal transition with rising blood pressure are particularly susceptible.

  • Pre-existing conditions: Heart failure, congenital long-QT syndrome, prior arrhythmia, primary hyperaldosteronism, Liddle syndrome, hypokalemic periodic paralysis, and severe liver disease all raise risk substantially.

  • Age-related considerations: Older adults experience higher baseline hypertension prevalence, reduced potassium tolerance, and more frequent diuretic and digoxin use, compounding risk.

  • Salt sensitivity and dietary sodium: High dietary sodium worsens both blood pressure elevation and edema from licorice; conversely, low dietary potassium magnifies hypokalemia.

Key Interactions & Contraindications

  • Diuretics (thiazides such as hydrochlorothiazide; loop diuretics such as furosemide): additive potassium loss; severity is high; absolute caution advised, with potassium monitoring if combined.

  • Cardiac glycosides (digoxin): hypokalemia from licorice potentiates digoxin toxicity, including arrhythmia; caution; monitor potassium and digoxin levels closely.

  • Antiarrhythmics (e.g., amiodarone, sotalol, dofetilide): QT prolongation risk magnified by licorice-induced hypokalemia; use only under close cardiology supervision.

  • Corticosteroids (prednisone, hydrocortisone): glycyrrhizin extends corticosteroid half-life and intensifies mineralocorticoid effects; avoid combination or reduce corticosteroid dose under supervision.

  • ACE inhibitors (angiotensin-converting enzyme inhibitors, blood-pressure medications such as lisinopril) and ARBs (angiotensin II receptor blockers, e.g., losartan): blood pressure–lowering effect blunted; monitor and adjust antihypertensive therapy.

  • Over-the-counter medications (NSAIDs such as ibuprofen and naproxen; OTC laxatives; OTC decongestants such as pseudoephedrine and phenylephrine): NSAIDs and decongestants can additionally raise blood pressure and worsen sodium retention; stimulant or osmotic laxatives can deplete potassium further; caution and self-monitoring of blood pressure are advised.

  • Hormonal contraceptives and hormone replacement therapy: weak phytoestrogenic effects of licorice may modify hormone levels and contribute to hypertension already associated with some hormonal therapies.

  • CYP3A4 substrates (statins like simvastatin, calcium-channel blockers, immunosuppressants such as tacrolimus and cyclosporine, and many psychoactive medications): modest CYP3A4 inhibition or induction (10–20% AUC — area under the concentration-time curve, a measure of total drug exposure — change) possible; relevant for narrow-therapeutic-index drugs.

  • Warfarin: potential interaction via CYP-mediated metabolism and platelet effects; monitor INR (international normalized ratio, a standardized measure of blood-clotting time).

  • Supplements: Additive blood pressure and potassium effects with supplements that retain sodium (high-dose glycyrrhizin in any form) or that lower potassium. Combination with other adaptogens that affect cortisol (rhodiola, ashwagandha) may produce unpredictable HPA-axis effects.

  • Populations to avoid: Those with hypertension, heart failure (NYHA — New York Heart Association — Class II–IV), chronic kidney disease (eGFR <60 mL/min/1.73 m²), hypokalemia, history of arrhythmia or long-QT syndrome, hyperaldosteronism, recent myocardial infarction (<90 days), pregnancy and lactation, and individuals on potassium-wasting diuretics or digoxin should avoid whole-root licorice and high-glycyrrhizin formulations.

Risk Mitigation Strategies

  • Use deglycyrrhizinated licorice (DGL) when possible: for digestive applications, DGL eliminates the mineralocorticoid risk; preserved benefits on mucosal protection and H. pylori suppression. Verify product specification: glycyrrhizin content should be <3% (ideally <1%). Mitigates: hypertension, hypokalemia, edema, arrhythmia.

  • Cap glycyrrhizin intake at 100 mg/day: the WHO and European Scientific Committee on Food upper limit; corresponds to roughly 0.2 g/kg of typical licorice candy or 1–2 g of dried root per day. Mitigates: cumulative pseudohyperaldosteronism.

  • Limit duration to 4–6 weeks: for whole-root licorice, avoid continuous use beyond 4–6 weeks without a washout. Mitigates: cumulative glycyrrhetinic acid accumulation, hormonal effects.

  • Monitor blood pressure weekly during active use: home blood pressure cuff readings; discontinue if systolic increases by ≥10 mmHg above baseline. Mitigates: undetected hypertension.

  • Check baseline and follow-up serum electrolytes: measure potassium and sodium at baseline and at 2–4 weeks if using whole-root licorice; discontinue for potassium <3.8 mmol/L. Mitigates: hypokalemia and arrhythmia.

  • Increase dietary potassium intake: target 3.5–4.7 g/day from leafy greens, beans, avocado, and potatoes during licorice use. Mitigates: hypokalemia.

  • Take in the morning if pursuing cortisol-extension benefits: avoid evening dosing to prevent sleep disruption. Mitigates: insomnia and cortisol-rhythm disruption.

  • Wash out before surgery: discontinue at least 2 weeks before elective surgery due to potential effects on blood pressure, electrolytes, and anesthesia interactions. Mitigates: perioperative complications.

Therapeutic Protocol

Licorice protocols vary substantially by indication and form. The following reflects standard practice across integrative and conventional sources.

  • DGL for digestive applications: chewable tablets standardized to <3% glycyrrhizin, 380–760 mg taken 20 minutes before meals, three times daily; chewing is required because saliva activates the mucosal protective effect. Used by integrative gastroenterologists for non-erosive reflux and dyspepsia.

  • Whole-root licorice for HPA support: capsules or tinctures providing 75–300 mg of standardized extract daily, taken in the morning to reinforce cortisol’s natural diurnal peak. Promoted by some functional medicine practitioners (e.g., Chris Kresser’s clinic) as a short-term tool in confirmed low-cortisol states.

  • Topical 1–5% licorice extract for aphthous ulcers or hyperpigmentation: applied two to three times daily to affected areas; treatment course typically 2–8 weeks.

  • Standardized licorice flavonoid extract (e.g., GutGard 150 mg twice daily) for functional dyspepsia: glycyrrhizin content kept low; used over 30-day cycles.

  • Time of day: morning dosing preferred for systemic preparations to align with cortisol’s natural peak and minimize sleep disruption; evening dosing avoided.

  • Half-life considerations: glycyrrhetinic acid has a terminal half-life of 8–48 hours depending on dose, so steady-state effects accumulate over several days; once-daily dosing is acceptable for systemic forms.

  • Single vs. split dosing: systemic doses are generally taken once or twice daily; DGL is split across meals because of its local mucosal mechanism.

  • Genetic considerations: carriers of HSD11B2 variants associated with reduced enzyme activity should avoid whole-root licorice; CYP3A4 polymorphism status may modify drug-interaction risk.

  • Sex-based differences: women may need lower doses for equivalent systemic effect; postmenopausal women using licorice for vasomotor symptoms typically use 75–150 mg of standardized extract.

  • Age considerations: for adults over 60, doses should be at the lower end of any range, with more frequent monitoring.

  • Baseline biomarkers: establish baseline blood pressure, serum potassium, and morning cortisol before starting whole-root preparations.

  • Pre-existing conditions: active hypertension, heart failure, kidney disease, or arrhythmia history are contraindications for whole-root licorice; DGL is generally acceptable.

Discontinuation & Cycling

  • Duration: licorice is generally short-term to medium-term (4–6 weeks for whole-root systemic use); DGL can be used longer for chronic mucosal indications.

  • Withdrawal effects: no addictive or rebound withdrawal syndrome is recognized; however, mineralocorticoid effects (blood pressure, potassium) take 2–6 weeks to resolve after discontinuation due to glycyrrhetinic acid’s prolonged tissue half-life.

  • Tapering protocol: for high-dose chronic users, gradual reduction over 1–2 weeks may smooth electrolyte normalization; sudden discontinuation is generally safe but should include electrolyte monitoring.

  • Cycling for tolerance or efficacy: some integrative protocols recommend a 2–4 week off-cycle every 4–6 weeks for whole-root preparations to limit cumulative mineralocorticoid effects; no efficacy-related tolerance has been documented.

Sourcing and Quality

  • Glycyrrhizin specification: for whole-root products, the label should state glycyrrhizin (or glycyrrhizic acid) content; for DGL, glycyrrhizin should be <3% (ideally <1%). Independent testing has found significant variation; ConsumerLab’s 2026 review found multiple DGL products exceeded their stated low-glycyrrhizin specifications.

  • Standardized extract preparations: look for products specifying flavonoid content (e.g., glabridin) or standardized to a defined glycyrrhizin percentage rather than raw root weight alone.

  • Third-party testing: prefer products with USP, NSF, or independent lab certifications confirming both potency and absence of contaminants (heavy metals, pesticides, and adulterants are documented in some commercial licorice).

  • Species identification: Glycyrrhiza glabra (European licorice) and Glycyrrhiza uralensis (Chinese licorice, Gan Cao) are the two main medicinal species; both contain glycyrrhizin but differ in flavonoid profile. Labels should specify species for traceability.

  • Reputable brands: Enzymatic Therapy (DGL), Integrative Therapeutics, Pure Encapsulations, Vital Nutrients, Natural Factors, and Thorne are commonly cited by integrative practitioners; ConsumerLab-tested brands provide additional assurance.

  • Compounded preparations: topical formulations for skin or oral applications are typically prepared by compounding pharmacies; licochalcone-rich and glabridin-standardized topicals are preferred for hyperpigmentation indications.

Practical Considerations

  • Time to effect: topical aphthous ulcer applications show benefit within 1–3 days; functional dyspepsia preparations within 2–4 weeks; topical hyperpigmentation responses require 8–12 weeks.

  • Common pitfalls: confusing whole-root licorice with DGL (with very different safety profiles); using black licorice candy as a “natural remedy” without dose awareness (typical candy concentrations are highly variable, with some confectionery-grade products approaching pharmacologic glycyrrhizin doses); failing to monitor blood pressure and potassium during chronic use; using during pregnancy or while on diuretics.

  • Regulatory status: in the United States, licorice root and DGL are sold as dietary supplements with no FDA approval for therapeutic claims; the FDA has issued specific public warnings about black licorice candy. The European Food Safety Authority sets a glycyrrhizin upper intake limit of 100 mg/day for general consumers.

  • Cost and accessibility: both whole-root and DGL preparations are inexpensive (typically less than $0.50 per day) and widely available without prescription. Topical compounded formulations and standardized flavonoid extracts (such as GutGard) are more expensive.

Interaction with Foundational Habits

  • Sleep: Whole-root licorice can disrupt sleep when taken in the evening through cortisol extension; the interaction is direct. Practical guidance: dose in the morning and avoid after midday. DGL has no documented sleep effect.

  • Nutrition: Direct interaction with sodium and potassium balance — high-sodium diets potentiate licorice’s blood pressure effect, while low-potassium diets magnify hypokalemia risk. Increase dietary potassium (leafy greens, avocado, beans, potatoes) and moderate sodium during use.

  • Exercise: Indirect interaction via electrolyte balance — endurance exercise produces additional potassium and sodium losses through sweat that may compound licorice-induced electrolyte shifts. Hydration and electrolyte replacement become more important during active use, particularly for those training in heat.

  • Stress management: Licorice potentiates the action of cortisol, which is already mobilized by chronic stress. This makes the interaction direct: combining licorice with high-stress periods may amplify the mineralocorticoid effects beyond what would be expected at a given dose. Stress-reduction practices (meditation, breathwork, sleep hygiene) become more important when using whole-root licorice for HPA support.

Monitoring Protocol & Defining Success

Baseline testing establishes a reference point before initiating whole-root licorice or other systemic glycyrrhizin-containing preparations; ongoing monitoring tracks the principal mineralocorticoid effects during use.

Ongoing monitoring cadence: blood pressure weekly during active use; serum electrolytes at baseline, 2–4 weeks, then every 4–6 weeks during continued use.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
Blood pressure (home) <125/80 mmHg Tracks the most common adverse effect Measure morning and evening; same arm; conventional hypertension cutoff is 130/80 mmHg
Serum potassium 4.0–4.8 mmol/L Detects hypokalemia Conventional reference range 3.5–5.0 mmol/L; functional medicine targets the upper half
Serum sodium 135–142 mmol/L Detects sodium retention Fasting morning sample; monitor for upper-end drift
Plasma renin activity 0.5–1.6 ng/mL/h Suppression indicates pseudohyperaldosteronism Useful if hypertension develops; suppressed renin with normal aldosterone confirms licorice-induced syndrome
Plasma aldosterone 4–31 ng/dL Distinguishes licorice effect from primary aldosteronism Suppressed in licorice-induced cases (unlike primary aldosteronism)
Morning cortisol (serum) 10–20 µg/dL Useful baseline if HPA-support indication Conventional reference 5–25 µg/dL; functional ranges narrower
eGFR >90 mL/min/1.73 m² Identifies kidney function affecting electrolyte handling Less margin for safety in chronic kidney disease (CKD); <60 is a contraindication
Liver enzymes (ALT/AST) <30 U/L Baseline before any chronic herbal use Conventional reference upper limit ~40 U/L; functional medicine targets <30
Total testosterone (men) 600–900 ng/dL Detects anti-androgenic effect Conventional range ~300–1000 ng/dL; consider checking after 4 weeks of high-dose use

Qualitative markers to track:

  • Energy and cortisol-rhythm symptoms (morning energy, afternoon crashes)
  • Edema (ankle swelling, ring or shoe tightness)
  • Headache frequency and intensity
  • Muscle weakness or cramping
  • Sleep quality and onset latency
  • Symptom resolution for the indication being treated (ulcer pain, dyspepsia, vasomotor symptoms)
  • Mood and stress response

Emerging Research

  • Low-dose licorice cardiovascular effects: Af Geijerstam et al., 2024 — randomized crossover trial in The American Journal of Clinical Nutrition showing measurable renin suppression, aldosterone changes, and home blood pressure increase from low daily licorice intake (well below current upper-limit thresholds), suggesting current safety guidance may underestimate sensitivity.

  • Combination herbal protocol for MAFLD (metabolic-associated fatty liver disease, fat accumulation in the liver linked to metabolic dysfunction): an active randomized trial (NCT06798948) evaluating Cynara scolymus, Silybum marianum, Curcuma longa, and Glycyrrhiza glabra combined for metabolic-associated fatty liver disease, Phase 2, 100 participants, primary endpoint MRI proton density fat fraction.

  • Rheumatoid arthritis ethnopharmacology review: Prajapati et al., 2026 — comprehensive review in the Journal of Ethnopharmacology of Glycyrrhiza glabra mechanisms in autoimmune inflammation, identifying synergistic strategies that could form the basis for human trials.

  • Glabridin in melasma combination protocols: ongoing research into glabridin-based topical depigmenting agents as alternatives to hydroquinone, with phase 2 dermatology trials evaluating efficacy and irritation profiles.

  • CYP3A4 induction studies: Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes (Liu et al., 2023) — clarifies the modest but reproducible 10–20% effect on midazolam exposure, with implications for narrow-therapeutic-index drug combinations.

  • HPA axis biomarker validation: future research areas include validating whether the “adrenal support” rationale for whole-root licorice corresponds to measurable improvements in cortisol awakening response and HPA-axis dynamic testing in symptomatic adults — currently the indication rests primarily on practitioner experience rather than controlled trials.

Conclusion

Licorice root sits at an unusual crossroads: a botanical with millennia of recorded medicinal use, a clear mechanistic profile, and a concentrated safety concern that drives every protocol decision. The strongest evidence supports topical applications — for canker sores and postoperative sore throat — where systemic glycyrrhizin exposure is minimal and benefits are well-replicated in randomized trials. The glycyrrhizin-removed form preserves the mucosal-protective and antimicrobial benefits relevant to digestive health while removing the cardiovascular and electrolyte risks, making it a pragmatic option for upper-gastrointestinal symptoms.

Whole-root systemic preparations occupy a more contested middle ground. Clinical signals exist for body composition, menopausal symptoms, hyperpigmentation, and stress-axis support, but each must be weighed against the well-documented blood-pressure, potassium, and hormonal effects. Even modest daily intake produces measurable changes in renin and home blood pressure, and the long elimination half-life of the active metabolite means consequences accumulate.

The evidence base is uneven: rigorous for topical and short-term systemic applications, more limited for chronic systemic use, and largely mechanistic for the longevity-adjacent claims. For health- and longevity-oriented adults, the practical signal is that form matters at least as much as dose, and that the cardiovascular and electrolyte signals associated with systemic exposure are central to interpreting any benefit claim.

Top - Benefits - Risks - Protocol